Cipla's Generic Alosetron Hydrochloride Receives Approval in US
Par Pharm’s Generic Alosetron Hydrochloride Receives Approval In US
Alosetron hydrochloride is the second new product to ship from Amneal in the 2017 calendar year following aspirin and extended-release dipyridamole capsules. Alosetron is Amneal's 105th molecule to be approved through the ANDA process and represents the company's first product in this therapeutic class. The Amneal product is one of only two FDA-approved generic-equivalents for Lotronex® currently available.
Amneal's Generic Alosetron Hydrochloride Receives Approval In US
In Case You Missed It ,We Did! Prometheus Takes Action Against FDA Over Generic LOTRONEX Approval...
Roxane`s Generic Alosetron Hydrochloride (Eq 0.5Mg, 1Mg Base) Approved in US For IBS